Clinical Trial Update: Clinical Evaluation of New Treatment Strategy of Mucous Membrane Pemphigoid Using Large Dose of Prednisolone Plus Intra-lesional of Triamcinolone Acetonide Followed by Combination of Mycophenolate Mofetil, Dapsone and Low Dose Prednisolone [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating a combination treatment strategy for benign mucous membrane pemphigoid, involving high-dose prednisolone with local triamcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucous Membrane Pemphigoid

Drugs mentioned

• DAPSONE (dapsone)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Prednisolone (Prednisolone)
• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Tanta University | Conditions: Benign Mucous Membrane Pemphigoid | Phase 2, Phase 3 | Status: UNKNOWN